- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
23 Cards in this Set
- Front
- Back
|
Local anesthetics
|
capsaicin, lidocaine
|
|
Antidepressants
|
TCAs, NSRIs, buproprion
|
|
Anticonvulsants
|
gabapentin, pregabalin, carbamazepine
|
|
Steroids
|
prednisone
|
|
Alpha 2 agonists
|
clonidine, tizanidine
|
|
Triptans
|
somatriptan
|
|
NMDA antagonists
|
dextromethorphan, ketamine, amantadine, memantine
|
|
Opioids: strong agonist
|
morphine, hydromorphone, tapentadol, meperidine, methadone, fentanyl, sulfentanil
|
|
Opioids: moderate/weak agonist
|
codeine, hydrocodone and oxycodone with acetaminophen
|
|
Opioids: atypical
|
tramadol, dextromethorphan
|
|
Opioids: partial agonist
|
buprenorphine
|
|
Opioids: mixed agonist antagonist
|
pentazocine
|
|
Opioid antagonist
|
naloxone (IV or intranasal), naltrexone (oral or sublingual), methylnaltrexone
|
|
Local anesthetics
|
Lidocaine - MOA: slow the rapid firing of Na+ channels
Capsaicin - MOA: May damage nerve endings, reduces their ability to send pain signals, that takes time to return to normal function |
|
TCA (first generation)
|
MOA: Alter neuronal sprouting
SE: daytime sleepiness, cognitive changes, dry mouth, orthostatic HTN |
|
Anticonvulsants
|
MOA: blocks alpha-2-delta subunit of Ca2+ channels, inhibits release of substance P and glutamate
SE: dizziness and sedation |
|
Opioids - agonists
|
MOA: reduces excitatory neuronal activity
SE: sedation, confusion, respiratory depression, pruritis, nausea and vomiting, tolerance |
|
Acetaminophen, ASA, NSAIDS
|
MOA: centrally to block TRPV1 (vallinoid receptors) and as COX inhibitor in the spinal cord and brain
MOA: irreversibly blocks cyclooxygenase required to produce prostaglandins and thromboxane MOA: reversibly inhibit COX enzymes and inhibit the production of prostaglandins |
|
Neurotransmitters
|
– endorphins – mu receptors
– enkephalins – delta receptors – dynorphin – kappa, bradykinin and NMDA receptors – nociceptin - ORL1 role in anxiety and depression |
|
Morphine
|
CAUSES MIOSIS
|
|
Meperidine
|
MOA: Increases serotonin
NOTE: metabolite appears to cause some tremors and delerium in susceptible people. Can accumulate in those with kidney dysfunction. Not recommended for management of chronic pain. Used in severe pain limited to 48 hours. CI: DO NOT USE WITH DRUGS THAT INCREASE 5-HT |
|
Methadone
|
may accumulate in tissues
|
|
CI for opioids
|
• Acute psychiatric instability, suicidality
• Current substance abuse that could have a negative drug drug interaction • Drug-drug interactions: meperidine and MAOIs, methadone and benzodiazepine, any in combination with alcohol, fentanyl and CYP 3A4 inhibitors • Active diversion of controlled substance • QTc interval >500msec for methadone use |